2 weeks Ago By ABMN Staff
Envestnet Asset Management Inc. lowered its position in shares of Globe Life Inc. ( NYSE:GL – Free Report ) by 2.
1% in the fourth quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 84,832 shares of the company’s stock after selling 1,828 shares during the period. Envestnet Asset Management Inc.
owned 0.10% of Globe Life worth $9,461,000 at the end of the most recent quarter. Several other large investors have also recently bought and sold shares of the business.
World Investment Advisors LLC raised its holdings in Globe Life by 34.7% during the third quarter. World Investment Advisors LLC now owns 5,704 shares of the company’s stock worth $604,000 after purchasing an additional 1,469 shares in the last quarter.
Retirement Systems of Alabama grew its position in shares of Globe Life by 6.4% in the 3rd quarter. Retirement Systems of Alabama now owns 19,702 shares of the company’s stock valued at $2,087,000 after buying an additional 1,179 shares during the last quarter.
DGS Capital Management LLC acquired a new stake in Globe Life during the 3rd quarter worth $212,000. Principal Financial Group Inc. lifted its position in Globe Life by 9.
0% in the third quarter. Principal Financial Group Inc. now owns 105,315 shares of the company’s stock valued at $11,154,000 after acquiring an additional 8,663 shares during the last quarter.
Finally, Versant Capital Management Inc boosted its stake in Globe Life by 388.0% in the fourth quarter. Versant Capital Management Inc now owns 244 shares of the company’s stock valued at $27,000 after acquiring an additional 194 shares in the last quarter.
Hedge funds and other institutional investors own 81.61% of the company’s stock. Analyst Ratings Changes GL has been the subject of several research reports.
Evercore ISI raised Globe Life from an “in-line” rating to an “outperform” rating and boosted their target price for the company from $132.00 to $143.00 in a report on Wednesday, January 8th.
BMO Capital Markets initiated coverage on Globe Life in a research note on Thursday, January 23rd. They issued a “market perform” rating and a $114.00 price objective for the company.
JPMorgan Chase & Co. raised their target price on shares of Globe Life from $136.00 to $145.
00 and gave the stock an “overweight” rating in a research report on Wednesday, April 2nd. Wells Fargo & Company reduced their price target on shares of Globe Life from $141.00 to $140.
00 and set an “overweight” rating for the company in a research report on Thursday, April 10th. Finally, Morgan Stanley lowered their price objective on shares of Globe Life from $126.00 to $117.
00 and set an “equal weight” rating on the stock in a research report on Thursday, April 10th. Five analysts have rated the stock with a hold rating, six have given a buy rating and one has assigned a strong buy rating to the company. Based on data from MarketBeat, the stock currently has a consensus rating of “Moderate Buy” and an average price target of $137.
55. Insiders Place Their Bets In other Globe Life news, CEO Frank M. Svoboda sold 11,000 shares of the business’s stock in a transaction on Thursday, February 13th.
The stock was sold at an average price of $122.31, for a total transaction of $1,345,410.00.
Following the sale, the chief executive officer now directly owns 18,948 shares in the company, valued at approximately $2,317,529.88. The trade was a 36.
73 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link . Also, CEO James Matthew Darden sold 24,890 shares of the company’s stock in a transaction on Tuesday, February 11th.
The shares were sold at an average price of $121.52, for a total value of $3,024,632.80.
Following the completion of the sale, the chief executive officer now directly owns 38,973 shares in the company, valued at $4,735,998.96. This trade represents a 38.
97 % decrease in their position. The disclosure for this sale can be found here . Insiders own 1.
51% of the company’s stock. Globe Life Trading Down 0.1 % Shares of Globe Life stock opened at $121.
09 on Friday. The company has a quick ratio of 0.05, a current ratio of 0.
05 and a debt-to-equity ratio of 0.50. The firm has a market cap of $10.
08 billion, a price-to-earnings ratio of 10.13 and a beta of 0.60.
Globe Life Inc. has a 52-week low of $64.50 and a 52-week high of $133.
76. The company’s 50-day simple moving average is $124.24 and its 200-day simple moving average is $115.
69. Globe Life ( NYSE:GL – Get Free Report ) last released its earnings results on Wednesday, February 5th. The company reported $3.
14 earnings per share (EPS) for the quarter, topping the consensus estimate of $3.12 by $0.02.
Globe Life had a return on equity of 22.32% and a net margin of 18.53%.
As a group, equities research analysts anticipate that Globe Life Inc. will post 13.87 earnings per share for the current year.
Globe Life Increases Dividend The firm also recently announced a quarterly dividend, which will be paid on Thursday, May 1st. Shareholders of record on Thursday, April 3rd will be issued a $0.27 dividend.
The ex-dividend date is Thursday, April 3rd. This represents a $1.08 dividend on an annualized basis and a yield of 0.
89%. This is an increase from Globe Life’s previous quarterly dividend of $0.24.
Globe Life’s dividend payout ratio (DPR) is 9.04%. Globe Life Company Profile ( Free Report ) Globe Life Inc, through its subsidiaries, provides various life and supplemental health insurance products, and annuities to lower middle- and middle-income families in the United States.
The company operates in four segments: Life Insurance, Supplemental Health Insurance, Annuities, and Investments. Recommended Stories Want to see what other hedge funds are holding GL? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Globe Life Inc.
( NYSE:GL – Free Report ). Receive News & Ratings for Globe Life Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Globe Life and related companies with MarketBeat.com's FREE daily email newsletter .
.
